Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
about
Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancerNovel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic miceThe Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer.The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cellsThe stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells.Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17β-HSD1 Inhibitor 16β-(m-Carbamoylbenzyl)estradiol.Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery
P2860
Q24293323-400CCB72-0239-4D16-BD71-4DDAEC7F0670Q33703792-9A1C5836-F045-4627-BC33-09A7BFE7052CQ33770742-41D6216B-EE0B-4C3C-B689-CC42F2D09948Q34130698-742CDAB5-4EA9-43CF-9159-72A42AC01EFEQ34856382-18B91DF1-DAB1-4AFB-9433-ECCDDE185D25Q35044178-33D00CA2-A3E2-4FA7-99B0-C2913FF0631BQ35832402-89E6371B-7CB3-47AE-8F2B-7F11D0AE1CB6Q36245433-00B362BA-FDEB-4E07-9F41-5BC8A38AC698Q36331426-3C332626-1160-4AFC-A4DA-DCEB6BED06DFQ37774374-D4C36825-E4EC-404F-A197-DB25755882EEQ38449142-0AF2DCE3-4216-4283-AB8F-01F4EE7B21D2Q49574243-AC947D9E-1DFA-461D-825A-6C95A32B01ECQ57072939-A1376683-E5B0-4337-99A4-DC0562A3D206
P2860
Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Relative involvement of three ...... es using selective inhibitors.
@en
Relative involvement of three ...... es using selective inhibitors.
@nl
type
label
Relative involvement of three ...... es using selective inhibitors.
@en
Relative involvement of three ...... es using selective inhibitors.
@nl
prefLabel
Relative involvement of three ...... es using selective inhibitors.
@en
Relative involvement of three ...... es using selective inhibitors.
@nl
P2093
P1476
Relative involvement of three ...... es using selective inhibitors.
@en
P2093
Claudine Rancourt
Donald Poirier
Yannick Laplante
P304
P356
10.1016/J.MCE.2008.08.026
P577
2008-09-04T00:00:00Z